Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYTM | AMGN | GILD | CELG | ILMN |
| Company | Rhythm Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 38.31 | 269.84 | 66.93 | 108.01 | 118.58 |
| High | 39.42 | 273.14 | 67.57 | 108.59 | 120.99 |
| Low | 37.76 | 269.84 | 66.74 | 107.27 | 117.48 |
| Last | 39.01 | 271.91 | 66.95 | 108.24 | 120.25 |
| Change | +1.00 | +2.98 | +0.19 | +0.11 | +2.82 |
| % Change | +2.63% | +1.11% | +0.28% | +0.10% | +2.40% |
| Volume | 390,300 | 2,165,700 | 5,622,300 | 191,230,496 | 1,151,100 |
| 20-Day Average Volume | 529,505 | 2,239,560 | 6,350,505 | 16,188,930 | 1,492,310 |
| Previous Close | 38.01 | 268.93 | 66.76 | 108.13 | 117.43 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 40.51 | 272.35 | 69.61 | 108.17 | 127.54 |
| 20-Day Raw Stochastic | 30.92% | 40.27% | 13.17% | 63.25% | 18.57% |
| 20-Day Relative Strength | 44.71% | 47.06% | 32.36% | 64.69% | 40.14% |
| Weighted Alpha | +52.26 | +10.54 | -20.99 | +46.30 | -39.11 |
| Today's Opinion | 8% Buy | 40% Sell | 100% Sell | 100% Buy | 72% Sell |
| Previous Opinion | 8% Buy | 56% Sell | 100% Sell | 100% Buy | 72% Sell |
| Last Month's Opinion | 40% Buy | 8% Buy | 88% Sell | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.69% since 04/15/24 | +2.41% since 04/15/24 | -1.18% since 04/15/24 | -1.97% since 11/13/19 | -0.75% since 04/15/24 |
| Low | 36.92 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 115.73 on 04/18/24 |
| High | 40.13 on 04/16/24 | 273.14 on 04/22/24 | 67.89 on 04/16/24 | 110.53 on 11/14/19 | 120.99 on 04/22/24 |
| 1-Month | |||||
| %Chg | -3.80% since 03/22/24 | -1.54% since 03/22/24 | -7.80% since 03/22/24 | +5.14% since 10/18/19 | -12.38% since 03/22/24 |
| Low | 36.92 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 43.68 on 04/09/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | -6.47% since 01/22/24 | -12.33% since 01/22/24 | -14.64% since 01/22/24 | +13.63% since 08/20/19 | -13.41% since 01/22/24 |
| Low | 36.92 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 52.57 on 02/12/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +77.32% since 10/20/23 | -2.47% since 10/20/23 | -13.95% since 10/20/23 | +14.14% since 05/20/19 | +0.51% since 10/20/23 |
| Low | 21.34 on 10/24/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 52.57 on 02/12/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,285,921 | 144,247,584 | 83,121,344 | 77,035,920 | 18,701,316 |
| Shares Outstanding, K | 60,140 | 536,376 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 77,430,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -184,680,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 24,230,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -41,630,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 1.90 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.70 on 02/22/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.09 | 9.85 | 10.99 | 134.13 |